Court WJ[au] - Search Results

Year	Number of Results
1994	1
1996	1
1999	1
2000	1
2007	1
2022	1
2024	0

1

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro.

Burmi RS, Box GM, Wazir U, Hussain HA, Davies JA, Court WJ, Eccles SA, Jiang WG, Mokbel K, Harvey AJ. Burmi RS, et al. Among authors: court wj. Genes (Basel). 2022 Feb 24;13(3):402. doi: 10.3390/genes13030402. Genes (Basel). 2022. PMID: 35327957 Free PMC article.

2

Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).

Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Eccles SA, et al. Among authors: court wj. Cancer Res. 1996 Jun 15;56(12):2815-22. Cancer Res. 1996. PMID: 8665519

3

The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) spontaneously forms conjugates with common components of cell culture medium.

Wilsher NE, Court WJ, Ruddle R, Newbatt YM, Aherne W, Sheldrake PW, Jones NP, Katan M, Eccles SA, Raynaud FI. Wilsher NE, et al. Among authors: court wj. Drug Metab Dispos. 2007 Jul;35(7):1017-22. doi: 10.1124/dmd.106.014498. Epub 2007 Apr 2. Drug Metab Dispos. 2007. PMID: 17403917

4

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: court wj. Cancer Res. 2000 Feb 15;60(4):1121-8. Cancer Res. 2000. PMID: 10706134

5

Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

O-charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: court wj. Clin Exp Metastasis. 1999;17(7):631-9. doi: 10.1023/a:1006751016860. Clin Exp Metastasis. 1999. PMID: 10845563

6

Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.

Eccles SA, Court WJ, Box GA, Dean CJ, Melton RG, Springer CJ. Eccles SA, et al. Among authors: court wj. Cancer Res. 1994 Oct 1;54(19):5171-7. Cancer Res. 1994. PMID: 7923136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year